Pharma Company Biokin Considers $432 Million Initial Public Offering in Hong Kong Amid Increased Fundraising Activity
November 7, 2025 — 12:55 CST
This Data Is Locked!
This area is available only to Subscribers.
Biokin, a leading Chinese pharmaceutical company, is currently evaluating a potential initial public offering (IPO) in Hong Kong. The IPO is expected to raise around... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
